Article info
Review
Protecting people with multiple sclerosis through vaccination
- Correspondence to Saúl Reyes, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark St, Whitechapel, London E1 2AT, UK; saul.reyes{at}nhs.net
Citation
Protecting people with multiple sclerosis through vaccination
Publication history
- Accepted May 26, 2020
- First published July 6, 2020.
Online issue publication
December 07, 2020
Article Versions
- Previous version (7 December 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- Principles of immunisation in children with solid organ transplant
- Multiple sclerosis and the risk of infection: Association of British Neurologists consensus guideline
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021
- Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
- EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases
- Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
- Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands
- MMR vaccine - how effective and how safe?